Clinical trial
Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events
NCT03708601 is registered in ClinicalTrials.gov with Beijing Institute of Heart, Lung and Blood Vessel Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events
- Lead sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 8, 2016
- Completion date
- August 8, 2022
- Enrollment
- 3,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.